Major Breakthrough in Diabetes Care in Tunisia: Revolutionary New Medication to Be Introduced
On Saturday, May 2, 2026, the Tunisian healthcare system is set to undergo a significant transformation with the official announcement of the introduction of a groundbreaking new medication. This development comes after the Central Pharmacy's circular was published yesterday, authorizing its release on the market. Patients will be able to obtain this treatment at pharmacies starting Wednesday, May 6, 2026, according to Dr. Tayssir Ben Houria, a pharmacist, during a press conference.
A Revolutionary Pen Injector for a Month of Treatment
The new device is a pen injector containing four doses, allowing for a single weekly administration. Primarily designed for adults suffering from type 2 diabetes, this treatment not only regulates blood sugar levels but also offers numerous additional benefits, including:
- Weight loss
- Improved cardiovascular health
- Enhanced safety for patients with kidney insufficiency
Access Conditions and Pricing
Although the medication has been approved by the Ministry of Health, its use is strictly regulated. It can only be dispensed with a prescription from a specialist to ensure optimal therapeutic follow-up. The cost of a single box, covering a full month of treatment, is set at 355 Tunisian dinars. Dr. Ben Houria has announced that negotiations will soon begin with the National Health Insurance Fund (CNAM) to explore the possibilities of covering this medication for social security beneficiaries.
Proven Efficacy and Rigorous Safety
The reliability of this treatment is based on extensive clinical trials involving over 10,000 patients worldwide. The results demonstrate a significant advantage in terms of blood sugar control and weight loss compared to traditional therapies. Already commercialized in over 70 countries, the medication has undergone thorough safety studies before its introduction in Tunisia. Health authorities emphasize the importance of strictly following usage guidelines and medical surveillance.
The Urgent Need for Effective Diabetes Treatment in Tunisia
The arrival of this therapeutic solution comes at a critical time, as 23% of the Tunisian population is affected by diabetes. The complexity of this disease is exacerbated by a high prevalence of excess weight and obesity among patients, which significantly increases the risk of cardiovascular and renal complications. In this context, access to more effective and easier-to-use treatments has become an imperative necessity to improve the quality of life for patients.
Key Takeaways
- A new revolutionary medication for diabetes treatment is set to be introduced in Tunisia on May 6, 2026.
- The medication is a pen injector containing four doses, allowing for a single weekly administration.
- It offers numerous benefits, including weight loss, improved cardiovascular health, and enhanced safety for patients with kidney insufficiency.
- The medication is strictly regulated and can only be dispensed with a prescription from a specialist.
- The cost of a single box is set at 355 Tunisian dinars.
- Negotiations will soon begin with the National Health Insurance Fund to explore the possibilities of covering this medication for social security beneficiaries.
